HIGH
Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX 77054, NDC 73702-302-31.
Wells Pharma of Houston
cGMP deviations.
HIGH
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Quick Facts at a Glance
- Recall Date
- April 1, 2026
- Hazard Level
- HIGH
- Brand
- Wells Pharma of Houston
- Geographic Scope
- 1 states
What to Do Now
Use this page like a recall checklist: verify the product first, then act on the official remedy.
Immediate steps
- 1Stop using the product until you confirm whether it is included in the recall.
- 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
- 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
- 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.
Check these identifiers
- Brand
- Wells Pharma of Houston
- Model numbers
- Lot 020226202150202, Exp Date 05/05/2026.
- Where affected
- ALL
Hazard Information
cGMP deviations.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Wells Pharma of Houston LLC or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Wells Pharma of Houston recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
Full Description
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.. Reason: cGMP deviations.. Classification: Class II. Quantity: 50 syringes. Distribution: U.S. Nationwide.
Browse More Recalls
Safety Guide
Not sure what to do next? Our guide walks you through the process step by step.
Read: How to Get Refunds and ReplacementsWant to Know First?
Get instant alerts for recalls that affect you. Free forever.
Product Classification
Product Details
Model Numbers
Lot 020226202150202
Exp Date 05/05/2026.
Affected States
ALL
Report Date
May 6, 2026
Source Agency
FDA - Drug SafetyRecall Status
ACTIVE
Related Recalls
HIGH
fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pharma of Houston, NDC 73702-204-25.
Wells Pharma of Houston
cGMP deviations.
HIGH
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC 73702-203-65.
Wells Pharma of Houston
cGMP deviations.
HIGH
fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, Wells Pharma in Houston, NDC 73702-202-02.
Wells Pharma of Houston
cGMP deviations.
HIGH
Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of Houston, NDC 73702-122-03
Wells Pharma of Houston
cGMP deviations.
HIGH
fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg per mL), 250 mL bag, wells pharma of Houston, NDC 73702-202-03.
Wells Pharma of Houston
cGMP deviations.